Dueling rulings on abortion pill Mifepristone pose challenges for FDA
Here & Now‘s Deepa Fernandes talks with STAT’s Sarah Owermohle about how the FDA is responding after conflicting rulings from Washington and Texas on the abortion pill mifepristone.
This article was originally published on WBUR.org.
Copyright 2023 NPR. To see more, visit https://www.npr.org.